Europe Biotech Market

The European biotech sector has had a bumpy past. Today, however it has reached a record momentum and is flourishing like never before. Stock exchanges, such as Euronext, support Biotech companies and have contributed largely to the record high we see today.

The global financial crisis hit Europe in 2008. Like a tidal wave, it tore through the biotech sector, leaving behind the debris of shattered companies and resulting in widespread cost-cutting with employees being laid off and research shelved. Nearly a decade later, the European biotech sector is flourishing again and has reached a momentum that was quite unforeseeable in the aftermath of 2008.

    Related Conference of Europe Biotech Market

    Europe Biotech Market Conference Speakers